Senseonics (NYSE:SENS) Reaches New 1-Year High – Still a Buy?

Shares of Senseonics Holdings, Inc. (NYSE:SENS) reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as $0.95 and last traded at $0.99, with a volume of 3044314 shares. The stock had previously closed at $0.91.

Analysts Set New Price Targets

A number of analysts recently commented on the company. StockNews.com assumed coverage on Senseonics in a research report on Thursday, December 26th. They set a “sell” rating for the company. HC Wainwright reaffirmed a “buy” rating and set a $2.00 price target on shares of Senseonics in a research report on Friday, November 15th.

Senseonics Stock Performance

The company’s 50-day simple moving average is $0.47 and its two-hundred day simple moving average is $0.41. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38.

Senseonics (NYSE:SENS) last announced its earnings results on Thursday, November 7th. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.01). Senseonics had a negative return on equity of 842.25% and a negative net margin of 362.30%. The company had revenue of $4.26 million during the quarter, compared to the consensus estimate of $4.02 million. On average, equities analysts anticipate that Senseonics Holdings, Inc. will post -0.14 EPS for the current year.

Insider Activity

In other news, CFO Frederick T. Sullivan acquired 124,933 shares of the firm’s stock in a transaction dated Thursday, December 12th. The shares were purchased at an average cost of $0.38 per share, for a total transaction of $47,474.54. Following the transaction, the chief financial officer now directly owns 2,478,844 shares of the company’s stock, valued at approximately $941,960.72. This trade represents a 5.31 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Timothy T. Goodnow bought 315,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The stock was purchased at an average cost of $0.31 per share, with a total value of $97,650.00. Following the acquisition, the chief executive officer now directly owns 11,310,355 shares in the company, valued at $3,506,210.05. This trade represents a 2.86 % increase in their position. The disclosure for this purchase can be found here. Insiders own 3.60% of the company’s stock.

Institutional Trading of Senseonics

Institutional investors have recently made changes to their positions in the business. Ridgecrest Wealth Partners LLC bought a new position in Senseonics in the 4th quarter worth approximately $60,000. FMR LLC lifted its holdings in shares of Senseonics by 48,267.2% in the third quarter. FMR LLC now owns 168,318 shares of the company’s stock worth $59,000 after buying an additional 167,970 shares in the last quarter. GSA Capital Partners LLP purchased a new position in shares of Senseonics in the third quarter worth $117,000. Cubist Systematic Strategies LLC boosted its position in shares of Senseonics by 25.9% during the second quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock worth $166,000 after acquiring an additional 85,501 shares during the last quarter. Finally, Symmetry Partners LLC purchased a new position in Senseonics during the third quarter valued at $164,000. Hedge funds and other institutional investors own 12.36% of the company’s stock.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.